Form 4 for PODD Insulet Corporation
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-13 · accession 0001127602-23-027356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-11-14 | 2023-11-13 | PODD | Petrovic Shacey | Dir | S - Sale+OE | $165.02 | -15.0K | 0 | -100% | -$2.48M |
| D | 2023-11-14 | 2023-11-13 | PODD | Petrovic Shacey | Dir | S - Sale+OE | $164.33 | -20.0K | 2,567 | -89% | -$3.29M |
| DM | 2023-11-14 | 2023-11-13 | PODD | Petrovic Shacey | Dir | M - OptEx | $81.69 | +20.0K | 22.6K | +779% | +$1.63M |
| DM | 2023-11-14 | 2023-11-13 | PODD | Petrovic Shacey | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | S | D | 2,075 | $165.02 | 41,130 | I | — | — | |
| 2 | Common | Common Stock | 2023-11-13 | S | D | 12,925 | $165.02 | 0 | I | — | — | |
| 3 | Common | Common Stock | 2023-11-13 | S | D | 20,000 | $164.33 | 2,567 | D | — | — | (F1) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $164.02 to $164.85. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-11-13 | M | A | 11,838 | $74.50 | 14,405 | D By NG Trust | — | — | |
| 5 | Common | Common Stock | 2023-11-13 | M | A | 8,162 | $92.11 | 22,567 | D By SP Trust | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-13 | M | D | 8,162 | $0.00 | 11,609 | D | $92.11 · — to 2029-02-26 | 8,162 Common Stock | (F3) This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-13 | M | D | 11,838 | $0.00 | 0 | D | $74.50 · — to 2028-02-14 | 11,838 Common Stock | (F2) This option, which is fully vested, vested over a four-year period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters. |